Chief Medical Officer
Dr. Colin Hayward, FFPM, is Premier Research’s top medical expert, providing global leadership for patient safety, scientific and ethical governance, and delivery of exemplary customer service.
Dr. Hayward embodies a rare combination of business and scientific expertise. After a career in hospital medicine with a focus on anesthesia and intensive care, he entered the pharmaceutical world. Using his expertise in local medical affairs and pharmacovigilance, Dr. Hayward became International Medical Leader at Roche, developing innovative medical marketing strategies for products in supportive care, anemia, and oncology.
“We have the expertise and flexibility to innovatively meet our customers’ most pressing needs.”
In 2007 he joined the board of Prism Ideas Ltd. After helping grow Prism and earning a Queen’s Award for business, he came to Premier Research in 2012, where he was the company’s Vice President of Medical Affairs, providing round-the-clock medical support to ensure that customers’ multimillion-euro drug development projects met their goals and adhered to stringent safety rules. He left Premier to serve as European Medical Director for Myriad Genetics, and returned to fill our newly created Chief Medical Officer position.
“The size of Premier Research and the quality of the people made me realize I could build on the great work already done by the team and have a big, direct impact on the success of our customers’ drug development plans and ultimately on the success of their businesses,” he said.
Dr. Hayward holds a degree in medicine from Guys and St. Thomas’s Hospitals, London. Outside work, he enjoys spending time with his family, playing hockey, and following Brighton and Hove Albion Football Club.